Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Study: Intervention raises costs for diabetes
Medical Economics, 10/21/09
Lewis M – Medical interventions for patients with type 2 diabetes won't reduce health costs over the long term, according to a recently published study, but that doesn't mean they don't offer benefits.
Related Articles
Autosomal recessive familial neurohypophyseal diabetes insipidus - onset in early infancy
European Journal of Endocrinology, 11/10/09
Relevance Score: 67%
Diverse Vasopressin V2 Receptor Functionality Underlying Partial Congenital Nephrogenic Diabetes Insipidus
American Journal of Physiology: Renal Physiology, 10/08/09
Relevance Score: 65%
Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus
Nephron: Physiology, 10/08/09
Relevance Score: 65%
Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy
Journal of Neuro-Oncology, 10/14/09
Relevance Score: 64%
Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Journal of General Internal Medicine, 11/09/09
Relevance Score: 48%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Stimulating EMR adoption
American Medical News , 11/25/09
Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals
BMC Health Services Research, 11/23/09
Microinsurance: Innovations In Low-Cost Health Insurance
Health Affairs, 11/19/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


